Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
APR Apria	$37.50	$37.45	$22.36 ▼ $40.00	$1.34B	N/A	682,285 shs	N/A
BLCO Bausch + Lomb	$13.52 -0.8%	$12.90	$10.45 ▼ $21.69	$4.82B	0.62	902,863 shs	1.16 million shs
LNTH Lantheus	$70.57 -0.9%	$77.65	$69.12 ▼ $118.21	$4.93B	0.14	1.02 million shs	943,059 shs
TFX Teleflex	$115.87 -3.0%	$118.73	$108.90 ▼ $249.90	$5.28B	1.08	535,501 shs	642,835 shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
APR Apria	0.00%	0.00%	0.00%	0.00%	0.00%
BLCO Bausch + Lomb	-1.13%	-5.13%	-1.74%	+17.87%	-21.49%
LNTH Lantheus	-0.87%	-3.24%	-11.37%	-35.10%	-32.68%
TFX Teleflex	-3.07%	-1.17%	-4.55%	-8.26%	-47.55%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
APR Apria	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
BLCO Bausch + Lomb	2.7267 of 5 stars	3.1	1.0	0.0	0.0	2.1	1.7	2.5
LNTH Lantheus	4.6193 of 5 stars	3.4	3.0	0.0	4.2	3.3	2.5	1.9
TFX Teleflex	4.7429 of 5 stars	3.0	3.0	2.5	3.9	3.2	1.7	2.5

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
APR Apria	0.00	N/A	N/A	N/A
BLCO Bausch + Lomb	2.20	Hold	$15.56	15.06% Upside
LNTH Lantheus	2.83	Moderate Buy	$131.20	85.91% Upside
TFX Teleflex	2.00	Hold	$141.57	22.18% Upside

Current Analyst Ratings Breakdown

Latest APR, BLCO, TFX, and LNTH Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/1/2025	BLCO Bausch + Lomb	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$12.00 ➝ $13.00
8/1/2025	TFX Teleflex	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Sector Perform ➝ Sector Perform	$130.00 ➝ $135.00
8/1/2025	TFX Teleflex	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$130.00 ➝ $135.00
8/1/2025	TFX Teleflex	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$137.00 ➝ $131.00
7/31/2025	BLCO Bausch + Lomb	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$15.00 ➝ $16.00
7/31/2025	BLCO Bausch + Lomb	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$12.00 ➝ $15.00
7/16/2025	LNTH Lantheus	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform
7/16/2025	TFX Teleflex	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$150.00 ➝ $130.00
7/15/2025	TFX Teleflex	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Sector Perform ➝ Sector Perform	$145.00 ➝ $130.00
7/9/2025	BLCO Bausch + Lomb	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$13.00 ➝ $15.00
7/8/2025	BLCO Bausch + Lomb	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$15.50 ➝ $16.00

(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
APR Apria	$1.15B	1.17	$5.27 per share	7.12	$1.12 per share	33.48
BLCO Bausch + Lomb	$4.79B	1.00	$1.86 per share	7.28	$18.39 per share	0.74
LNTH Lantheus	$1.53B	3.18	$7.04 per share	10.03	$15.65 per share	4.51
TFX Teleflex	$3.05B	1.68	$24.60 per share	4.71	$96.02 per share	1.21

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
APR Apria	$64.88M	N/A	0.00	20.49	N/A	5.66%	586.18%	9.23%	N/A
BLCO Bausch + Lomb	-$317M	-$0.78	N/A	14.08	1.52	-5.58%	2.33%	1.12%	N/A
LNTH Lantheus	$312.44M	$3.52	20.05	11.18	N/A	16.55%	36.99%	20.55%	8/6/2025 (Estimated)
TFX Teleflex	$69.68M	$4.25	27.26	7.63	1.87	6.31%	15.08%	8.85%	N/A

Latest APR, BLCO, TFX, and LNTH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2025	Q2 2025	LNTH Lantheus	$1.65	N/A	N/A	N/A	$389.69 million	N/A
7/31/2025	Q2 2025	TFX Teleflex	$3.36	$3.73	+$0.37	$2.77	$771.53 million	$780.90 million
7/30/2025	Q2 2025	BLCO Bausch + Lomb	$0.06	$0.07	+$0.01	-$0.18	$1.25 billion	$1.28 billion
5/7/2025	Q1 2025	LNTH Lantheus	$1.64	$1.53	-$0.11	$1.02	$377.37 million	$372.76 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
APR Apria	N/A	N/A	N/A	N/A	N/A
BLCO Bausch + Lomb	N/A	N/A	N/A	N/A	N/A
LNTH Lantheus	N/A	N/A	N/A	N/A	N/A
TFX Teleflex	$1.36	1.17%	N/A	32.00%	N/A

Latest APR, BLCO, TFX, and LNTH Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/31/2025	TFX Teleflex	quarterly	$0.34	1.19%	8/15/2025	8/15/2025	9/15/2025
5/12/2025	TFX Teleflex	quarterly	$0.34	1.09%	5/20/2025	5/20/2025	6/16/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
APR Apria	8.58	1.09	1.06
BLCO Bausch + Lomb	0.76	1.55	0.96
LNTH Lantheus	0.49	5.74	5.46
TFX Teleflex	0.42	2.41	1.32

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
APR Apria	N/A
BLCO Bausch + Lomb	11.07%
LNTH Lantheus	99.06%
TFX Teleflex	95.62%

Insider Ownership

Company	Insider Ownership
APR Apria	N/A
BLCO Bausch + Lomb	0.76%
LNTH Lantheus	1.50%
TFX Teleflex	1.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
APR Apria	6,080	35.65 million	N/A	Not Optionable
BLCO Bausch + Lomb	13,500	353.80 million	351.12 million	Optionable
LNTH Lantheus	700	69.19 million	68.15 million	Optionable
TFX Teleflex	14,100	44.19 million	43.57 million	Optionable

APR, BLCO, TFX, and LNTH Headlines

Recent News About These Companies

Teleflex Raises 2025 Guidance After BIOTRONIK Acquisition

1 hour ago | theglobeandmail.com

Mackenzie Financial Corp Raises Stock Holdings in Teleflex Incorporated (NYSE:TFX)

4 hours ago | marketbeat.com

Universal Beteiligungs und Servicegesellschaft mbH Decreases Stock Position in Teleflex Incorporated (NYSE:TFX)

4 hours ago | marketbeat.com

Wall Street Zen Upgrades Teleflex (NYSE:TFX) to Strong-Buy

August 2 at 3:08 AM | marketbeat.com

Teleflex (NYSE:TFX) Shares Gap Up on Earnings Beat

August 2 at 2:45 AM | americanbankingnews.com

Teleflex price target raised to $135 from $130 at Mizuho

August 1 at 3:11 PM | msn.com

Teleflex (NYSE:TFX) Updates FY 2025 Earnings Guidance

August 1 at 12:23 PM | marketbeat.com

Teleflex (NYSE:TFX) Shares Gap Up After Better-Than-Expected Earnings

August 1 at 11:06 AM | marketbeat.com

Teleflex Incorporated (NYSE:TFX) Q2 2025 Earnings Call Transcript

August 1 at 10:04 AM | msn.com

Teleflex Incorporated (NYSE:TFX) to Issue Quarterly Dividend of $0.34

August 1 at 9:38 AM | marketbeat.com

Teleflex Incorporated (TFX) Q2 2025 Earnings Conference Call Transcript

July 31 at 8:27 PM | seekingalpha.com

Teleflex Incorporated 2025 Q2 - Results - Earnings Call Presentation

July 31 at 7:13 PM | seekingalpha.com

Teleflex price target raised to $135 from $130 at RBC Capital

July 31 at 7:01 PM | msn.com

Teleflex (NYSE:TFX) Beats Q2 Sales Targets

July 31 at 7:01 PM | finance.yahoo.com

Compared to Estimates, Teleflex (TFX) Q2 Earnings: A Look at Key Metrics

July 31 at 10:31 AM | zacks.com

Teleflex (TFX) Q2 Earnings and Revenues Top Estimates

July 31 at 8:45 AM | zacks.com

Teleflex Announces Quarterly Dividend

July 31 at 6:45 AM | globenewswire.com

Teleflex Incorporated Reports Strong Q2 2025 Financial Results and Raises Guidance

July 31 at 6:44 AM | quiverquant.comQ

Teleflex Non-GAAP EPS of $3.73 beats by $0.36, revenue of $780.9M beats by $9.37M

July 31 at 6:44 AM | seekingalpha.com

Teleflex Reports Second Quarter Financial Results and Full Year 2025 Outlook

July 31 at 6:30 AM | globenewswire.com

Teleflex Q2 2025 Earnings Preview

July 30 at 1:41 PM | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

APR, BLCO, TFX, and LNTH Company Descriptions

Apria NYSE:APR

Apria, Inc. provides integrated home healthcare equipment and related services in the United States. The company offers home respiratory therapies, including the supply of stationary and portable home oxygen equipment, and non-invasive ventilators; obstructive sleep apnea therapy devices comprising continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services; and negative pressure wound therapy products. It also provides a range of home medical equipment and other products, and services for patients with home care needs; and clinical and administrative support services, and related products and supplies to patients. Apria, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana. As of March 29, 2022, Apria, Inc. operates as a subsidiary of Byram Healthcare Centers, Inc.

Bausch + Lomb NYSE:BLCO

$13.52 -0.11 (-0.81%)

Closing price 08/1/2025 03:59 PM Eastern

Extended Trading

$13.75 +0.23 (+1.67%)

As of 08/1/2025 07:24 PM Eastern

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. Its Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation is a subsidiary of Bausch Health Companies Inc.

Lantheus NASDAQ:LNTH

$70.57 -0.62 (-0.87%)

Closing price 08/1/2025 04:00 PM Eastern

Extended Trading

$70.74 +0.17 (+0.23%)

As of 08/1/2025 07:51 PM Eastern

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent to assess blood flow to the muscle of the heart; and PYLARIFY, an F 18-labelled PSMA-targeted PET imaging agent used for imaging of PSMA positive-lesions in men with prostate cancer. The company also offers Automated Bone Scan Index that calculates the disease burden of prostate cancer by detecting and classifying bone scan tracer uptakes as metastatic or benign lesions using an artificial neural network; RELISTOR for opioid-induced constipation; and aPROMISE, an artificial intelligence medical device software; and PYLARIFY AI, an AI-based medical device software to perform quantitative assessment of PSMA PET/CT images in prostate cancer. In addition, it develops 1095, a PSMA-targeted iodine-131-labeled small molecule; PNT2002, a radiopharmaceutical therapy to treat mCRPC; PNT2003, an SSTR therapy that treats patients with SSTR-positive neuroendocrine tumors; MK-6240, a F 18-labeled PET imaging agent that targets Tau tangles in Alzheimer's disease; LNTH-1363S, an fibroblast activation protein, alpha targeted, copper-64 labeled PET imaging agent; and flurpiridaz used to assess blood flow to the heart;. It has collaboration agreements with GE Healthcare; NanoMab Technology Limited; Curium; RefleXion Medical, Inc.; POINT; Regeneron Pharmaceuticals, Inc; and Ratio Therapeutics LLC. The company was founded in 1956 and is based in Bedford, Massachusetts.

Teleflex NYSE:TFX

$115.87 -3.63 (-3.04%)

Closing price 08/1/2025 03:59 PM Eastern

Extended Trading

$116.98 +1.10 (+0.95%)

As of 08/1/2025 07:18 PM Eastern

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time